Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson monthly Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E28.32 EPS (ttm)5.25 Insider Own0.07% Shs Outstand2.64B Perf Week1.03%
Market Cap391.41B Forward P/E16.34 EPS next Y9.09 Insider Trans0.16% Shs Float2.63B Perf Month1.69%
Income14.15B PEG4.82 EPS next Q1.87 Inst Own69.80% Short Float0.78% Perf Quarter14.96%
Sales81.71B P/S4.79 EPS this Y7.60% Inst Trans-0.17% Short Ratio3.10 Perf Half Y14.45%
Book/sh22.09 P/B6.72 EPS next Y4.93% ROA9.20% Target Price156.63 Perf Year15.32%
Cash/sh6.81 P/C21.81 EPS next 5Y5.87% ROE23.80% 52W Range125.00 - 150.17 Perf YTD1.82%
Dividend3.80 P/FCF39.62 EPS past 5Y3.10% ROI17.00% 52W High-1.09% Beta0.70
Dividend %2.56% Quick Ratio1.00 Sales past 5Y2.70% Gross Margin66.60% 52W Low18.82% ATR1.84
Employees135100 Current Ratio1.30 Sales Q/Q1.90% Oper. Margin19.90% RSI (14)70.76 Volatility1.50% 1.15%
OptionableYes Debt/Eq0.49 EPS Q/Q-54.50% Profit Margin17.30% Rel Volume1.23 Prev Close148.25
ShortableYes LT Debt/Eq0.46 EarningsJan 22 BMO Payout69.50% Avg Volume6.62M Price148.53
Recom2.10 SMA201.59% SMA505.11% SMA2009.23% Volume8,671,988 Change0.19%
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Jan-23-20 06:00PM  Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments GuruFocus.com
11:45AM  Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy? Zacks
10:36AM  US Indexes End Mostly Flat Wednesday GuruFocus.com
07:00AM  This Medical Giant Just Topped An Entry Should You Buy ABT Stock Now? Investor's Business Daily
06:30AM  JNJ Stock Recently Hit A Fresh High Is It Time To Buy Shares? Investor's Business Daily
06:30AM  Johnson & Johnson Sold a Hot Biotech Stock Barrons.com
Jan-22-20 11:13PM  Edited Transcript of JNJ earnings conference call or presentation 22-Jan-20 1:00pm GMT Thomson Reuters StreetEvents
04:25PM  Dow Jones Medical Giant Johnson & Johnson Slips On Mixed Quarter Investor's Business Daily
04:19PM  Stocks close steady but off highs with China taking steps to contain possible pandemic MarketWatch
01:42PM  US STOCKS-S&P 500, Nasdaq hit record highs on IBM, chip power Reuters
12:58PM  US Markets in the Green on Wednesday GuruFocus.com
12:47PM  Johnson & Johnson's Earnings Surpass Expectations, but Revenue Falls Short GuruFocus.com
12:41PM  Why one stock-market bull says hes taking the offense off the field MarketWatch
11:59AM  US STOCKS-S&P 500, Nasdaq hit record highs on IBM, chip power Reuters
11:02AM  J&J Looks to Fend Off Challenges to Key Drugs, Consumer Products Bloomberg
10:45AM  J&J forecasts weak annual profit, misses revenue estimates Reuters
10:42AM  Breaking Q4 Earnings News Zacks
10:41AM  Johnson & Johnson misses revenue estimates Reuters Videos
10:33AM  J&J's (JNJ) Q4 Earnings Surpass Estimates, Sales Fall Short Zacks
10:32AM  US STOCKS-S&P 500, Nasdaq hit record on IBM, waning China virus fears Reuters
10:24AM  Chicago Econ Numbers & More Q4 Earnings: JNJ, ABT, FITB Zacks
09:57AM  Dow Jones Today: IBM, Tesla Lead, Netflix Slips, As Stock Market Looks For A Bounce Investor's Business Daily
09:37AM  Johnson & Johnsons Earnings Were Good Enough for Wall Street Analysts. The Stock Is Falling Anyway. Barrons.com
09:15AM  Rally Pauses as Coronavirus Spreads to U.S. Zacks
09:13AM  US STOCKS-S&P 500, Nasdaq aim for record on IBM earnings, fading China virus fears Reuters
08:50AM  What to Watch Wednesday: Tesla's Market Cap, Apple's New iPhone and Johnson & Johnson TheStreet.com
08:26AM  IBM Stock Is Surging, J&J Slips as China Virus Fears Fade and the Dow Gains Barrons.com
08:10AM  Dow getting a 22-point boost from IBM's stock rally, J&J's decline after earnings MarketWatch
08:00AM  US STOCKS-S&P 500 aims for record open on IBM support, fading China virus fears Reuters
07:45AM  Johnson & Johnson (JNJ) Q4 Earnings Beat Estimates Zacks
06:40AM  Johnson & Johnson's stock slips after profit rises above expectations, but sales comes up a bit shy MarketWatch
02:18AM  Stocks - Wall Street to Push Higher; Netflix, IBM Gain Investing.com
02:13AM  Johnson & Johnson Tops Q4 Earnings Forecast, But Light Revenue, Remicade Sales Hit Shares TheStreet.com
02:12AM  J&J Raises Underlying Guidance After Strong Q4, but Legal Risks Linger Investing.com
Jan-21-20 03:02PM  Triad label printing firm grows on technology investment American City Business Journals
01:43PM  Johnson & Johnson's Q4 Earnings Outlook Benzinga
12:52PM  Day Ahead: Top 3 Things to Watch for Jan. 22 Investing.com
08:48AM  Why Earnings Season Could Be Great for Johnson & Johnson (JNJ) Zacks
08:00AM  Pharma firms not making enough progress against superbugs - report Reuters
07:18AM  Netflix, Intel and IBM set to enter battle against the earnings recession MarketWatch
Jan-20-20 02:04PM  The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings Benzinga
10:52AM  Fourth Quarter Earnings Reports in Week Ahead Zacks
10:06AM  On MLK Day, a Busy Week Expected Zacks
09:52AM  Netflix, Johnson & Johnson, Procter & Gamble and Intel are part of Zacks Earnings Preview Zacks
09:08AM  As the stock market races to uncharted territory, irrationally bullish investors are getting nervous MarketWatch
09:03AM  AstraZeneca Announces Positive FDA Updates on Cancer Drugs Zacks
08:17AM  J&J's $8B Jury Award in Risperdal Case Cut to $6.8M by Judge Zacks
Jan-19-20 08:43AM  Earnings, Davos What to know in the week ahead Yahoo Finance
Jan-18-20 05:55PM  This is nuts one strategist explains why he just reduced risk by selling Apple, Microsoft and more MarketWatch
09:35AM  If You Had Bought Johnson & Johnson (NYSE:JNJ) Shares Five Years Ago You'd Have Made 46% Simply Wall St.
03:01AM  Judge cuts $8bn J&J Risperdal verdict to $6.8m Financial Times
02:40AM  Drugmakers slash prices to be eligible for China's bulk-buy program Reuters
Jan-17-20 05:24PM  Yacktman Focused Fund's Top 5 Sells in the 4th Quarter GuruFocus.com
04:37PM  Judge Cuts $8 Billion J&J Jury Award to $6 Million Barrons.com
03:37PM  Q4 Earnings Season Showing Revenue Momentum Zacks
01:54PM  Judge slashes $8 bln Risperdal award against Johnson & Johnson to $6.8 mln Reuters
11:50AM  The Zacks Analyst Blog Highlights: AAPL, JNJ, PG and AXP Zacks
11:43AM  The Zacks Analyst Blog Highlights: JPM, JNJ, CVX and PG Zacks
11:41AM  The Zacks Analyst Blog Highlights: JNJ, BHP, MCO, NVDA and DAL Zacks
09:45AM  Is Johnson & Johnson (JNJ) A Good Pick for Value Investors? Zacks
08:19AM  Will J&J (JNJ) Roll Out Pharma Q4 Earnings With a Beat? Zacks
08:11AM  Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates Zacks
Jan-16-20 04:32PM  Yacktman Fund's Biggest Buys of 4th-Quarter 2019 GuruFocus.com
02:41PM  Q4 Earnings Scorecard & Today's Top Stock Research Reports Zacks
12:10PM  Will Dow ETFs Continue to Surge as Q4 Earnings Unfold? Zacks
11:31AM  T. Rowe Price Equity Income Fund Invests in Utility Company CenterPoint Energy GuruFocus.com
09:05AM  4 Blue-Chip Stocks to Win Big on Phase-One Trade Deal Zacks
09:01AM  J&J Seeks Label Expansion for Spravato Nasal Spray in EU Zacks
08:55AM  3 Medical Product Stocks Set to Beat This Earnings Season Zacks
07:56AM  4 Must-Buy Dow Stocks Ahead of Earnings Reports This Month Zacks
06:41AM  Healthcare AI firm hiring, considering M&A after $150M raise American City Business Journals
Jan-15-20 05:45PM  Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know Zacks
01:11PM  Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release Zacks
08:00AM  3 Large-Cap Dividend Stocks to Buy Now for Your 2020 Portfolio Zacks
Jan-14-20 01:03PM  Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson Moody's
08:55AM  Healthpeak (PEAK) Leases Phase II at The Shore at Sierra Point Zacks
Jan-13-20 12:10PM  Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again Zacks
10:34AM  New Study Could Clear Johnson & Johnson on Talc, but Is It a Buy Signal? GuruFocus.com
10:26AM  Glaxo Files Marketing Application for Fostemsavir in Europe Zacks
09:36AM  The Zacks Analyst Blog Highlights: JPMorgan Chase, Johnson & Johnson, American Express Company, NIKE and Apple Zacks
07:58AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jan-10-20 03:43PM  California may become first state to sell its own prescription drugs Yahoo Finance Video
02:48PM  Harold Burson, PR legend, dies at 98 American City Business Journals
12:18PM  Should Investors Buy Johnson & Johnson Stock Prior to Earnings? InvestorPlace
12:08PM  7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount InvestorPlace
06:38AM  Dow Heads Toward 29,000: Grab 5 Blue-Chip Stocks Now Zacks
Jan-09-20 05:45PM  Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
09:20AM  4 Things to Pay Attention to at the J.P. Morgan Health-Care Conference Next Week Barrons.com
07:00AM  Johnson & Johnson spinout signs licensing, collaboration deal worth up to $1.4B American City Business Journals
Jan-08-20 11:34AM  Jabil Inc. -- Moody's rates Jabil's new notes Baa3, outlook stable Moody's
11:16AM  Pacira's (PCRX) Exparel Meets Key Goals in C-Section Study Zacks
08:13AM  3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020 Zacks
08:00AM  ISRG Stock: Should You Invest In This Robotic Surgery Giant? Investor's Business Daily
07:00AM  Cambridge startup bringing AI to drug development raises $60M American City Business Journals
Jan-07-20 04:35PM  Dow Jones Today: Middle East Focus Factors Into The Equation Again InvestorPlace
11:27AM  Ignore the Analysts: Johnson & Johnson Faces Serious Legal Liability InvestorPlace
09:59AM  Protagonist (PTGX) Starts Study on PTG-300 for Blood Disorder Zacks
Jan-06-20 02:18PM  Johnson & Johnson Reportedly Settles California Talc Case Midtrial Benzinga
01:52PM  New antibiotics struggle to generate sales, pharma companies hurt Yahoo Finance Video
11:14AM  Dow down 50 points on losses for Walt Disney, Johnson & Johnson stocks MarketWatch
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Joly HubertDirectorDec 13Buy141.285,000706,3995,000Dec 16 04:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Option Exercise62.622,017126,30551,736Dec 16 05:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Sale141.072,017284,53849,719Dec 16 05:40 PM
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM